Juan F. Galvez-Florez, MD

Universidad El Bosque, Faculty of Medicine, Center for Clinical and Translational Research, Bogotá, Colombia

JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe